Bellevue Group’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78M | Hold |
|
|||||
|
2025
Q1 | $4.24M | Sell |
|
|||||
|
2024
Q4 | $18.2M | Hold |
|
|||||
|
2024
Q3 | $37.1M | Hold |
|
|||||
|
2024
Q2 | $39.7M | Hold |
|
|||||
|
2024
Q1 | $43.2M | Sell |
|
|||||
|
2023
Q4 | $24M | Buy |
|
|||||
|
2023
Q3 | $23.3M | Hold |
|
|||||
|
2023
Q2 | $41.1M | Buy |
|
|||||
|
2023
Q1 | $10.2M | Sell |
|
|||||
|
2022
Q4 | $9.72M | Buy |
|
|||||
|
2022
Q3 | $7.97M | Hold |
|
|||||
|
2022
Q2 | $11.6M | Buy |
|
|||||
|
2022
Q1 | $9.12M | Sell |
|
|||||
|
2021
Q4 | $18.5M | Hold |
|
|||||
|
2021
Q3 | $29.3M | Hold |
|
|||||
|
2021
Q2 | $42.2M | Buy |
|
|||||
|
2021
Q1 | $54.4M | Buy |
|
|||||
|
2020
Q4 | $45M | Hold |
|
|||||
|
2020
Q3 | $42.4M | Hold |
|
|||||
|
2020
Q2 | $59.1M | Buy |
|
|||||
|
2020
Q1 | $33.2M | Buy |
|